Coenzyme Q10 production in recombinant Escherichia coli strains engineered with a heterologous decaprenyl diphosphate synthase gene and foreign mevalonate pathwayCoenzyme Q<sub>10</sub> production in recombinant <i>Escherichia coli</i> strains engineered with a heterologous decaprenyl diphosphate synthase gene and foreign mevalonate pathway
- Other Titles
- Coenzyme Q<sub>10</sub> production in recombinant <i>Escherichia coli</i> strains engineered with a heterologous decaprenyl diphosphate synthase gene and foreign mevalonate pathway
- Authors
- Zahiri, Hossein Shahbani; Yoon, Sang Hwal; Keasling, Jay. D.; Lee, Si Hyoung; Kim, Seon Won; Yoon, Sung Chul; Shin, Yong Chul
- Issue Date
- Sep-2006
- Publisher
- Academic Press
- Keywords
- coenzyme Q10; ddsA gene; mevalonate pathway; metabolic engineering; IPP; Escherichia coli
- Citation
- Metabolic Engineering, v.8, no.5, pp 406 - 416
- Pages
- 11
- Indexed
- SCIE
SCOPUS
- Journal Title
- Metabolic Engineering
- Volume
- 8
- Number
- 5
- Start Page
- 406
- End Page
- 416
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/73694
- DOI
- 10.1016/j.ymben.2006.05.002
- ISSN
- 1096-7176
1096-7184
- Abstract
- In the present work, Escherichia coli DH5 alpha was metabolically engineered for CoQ(10) production by the introduction of decaprenyl diphosphate synthase gene (ddsA) from Agrobacterium tumefaciens. Grown in 2YTG medium (1.6% tryptone, 1% yeast extract, 0.5% NaCl, and 0.5% glycerol) with an initial pH of 7, the recombinant E coli was capable of CoQ(10) production up to 470 mu g/gDCW (dry cell weight). This value could be further elevated to 900 mu g/gDCW simply by increasing the initial culture pH from 7 to 9. Supplementation of 4-hydroxy benzoate did not improve the productivity any further. However, engineering of a lower mevalonate semi-pathway so as to increase the isopentenyl diphosphate (IPP) supply of the recombinant strain using exogenous mevalonate efficiently increased the CoQ(10) production. Lower mevalonate semi-pathways of Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Enterococcus faecalis, and Saccharomyces cerevisiae were tested. Among these, the pathway of Streptococcus pneumoniae proved to be superior, yielding CoQ(10) production of 2700 +/- 115 mu g/gDCW when supplemented with exogenous mevalonate of 3 mM. In order to construct a complete mevalonate pathway, the upper semi-pathway of the same bacterium, Streptococcus pneumoniae, was recruited. In a recombinant iE coli DH5 alpha harboring three plasmids encoding for upper and lower mevalonate semi-pathways as well as DdsA enzyme, the heterologous mevalonate pathway could convert endogenous acetyl-CoA to IPP, resulting in CoQ(10) production of up to 2428 +/- 75 mu g/gDCW, without mevalonate supplementation. In contrast, a whole mevalonate pathway constructed in a single operon was found to be less efficient. However, it provided CoQ(10) production of up to 1706 +/- 86 mu g/gDCW, which was roughly 1.9 times higher than that obtained by ddsA alone. (C) 2006 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 자연과학대학 > Division of Life Sciences > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.